ITM Isotope Technologies Munich SE

Stories

Telix acquires isotope maker ITM in deal worth up to $2.35 billion

As of September 2026: Acquisition target; privately held

Telix Pharmaceuticals, an Australian maker of cancer imaging and treatment agents, agreed on September 21 to buy German isotope producer ITM Isotope Technologies Munich. The deal is worth up to $2.35 billion all-in, with $1.65 billion paid upfront, most of it in Telix shares.

Updated Sep 21